Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Hyal-Plus** is an oral nutraceutical product from Elliott Labs containing rosehip extract, *Boswellia serrata*, vitamin C, and piperine. Elliott Labs presents it for joint-health and inflammatory musculoskeletal conditions including osteoarthritis, rheumatoid arthritis, facet arthropathy, and ankylosing spondylitis. The botanical components are intended to provide anti-inflammatory and antioxidant support, vitamin C supports collagen formation, and piperine is commonly included to enhance absorption of co-administered constituents. Public product-page information does not specify standardized extract content, molecular targets, or clinical-trial evidence for the finished product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hyal-Plus.